Should We Adjust Low-Density Lipoprotein Cholesterol Management to the Severity of Coronary Artery Disease?

被引：3
|
作者：
Weintraub, William S. [1 ]
Arbab-Zadeh, Armin [2 ]
机构：
[1] Georgetown Univ, MedStar Washington Hosp Ctr, Washington, DC USA
[2] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
来源：
JACC-CARDIOVASCULAR IMAGING | 2020年 / 13卷 / 09期
关键词：
coronary artery calcium score; coronary CT angiography; low-density lipoprotein cholesterol; prevention of cardiovascular disease; AMERICAN-HEART-ASSOCIATION; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; LDL-CHOLESTEROL; RISK; ATHEROSCLEROSIS; THERAPY; GUIDELINES; STATEMENT; OUTCOMES;
D O I：
10.1016/j.jcmg.2020.04.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1973 / 1975
页数：3
相关论文
共 50 条
  • [21] Very low-density lipoprotein cholesterol is associated with extent and severity of coronary artery disease in patients with type 2 diabetes mellitus
    Jia, Aimei
    Zeng, Wei
    Yu, Liuqin
    Zeng, Huirun
    Lu, Zhan
    Song, Yongyan
    [J]. SAGE OPEN MEDICINE, 2019, 7
  • [22] Attainment of Low-density Lipoprotein Cholesterol Goals in a High Risk Coronary Artery Disease Population
    Kauffman, Amy
    Olson, Kari
    Zadvorny, Emily
    Youngblood, Morgan
    Delate, Thomas
    Merenich, John
    [J]. CIRCULATION, 2009, 120 (18) : S465 - S466
  • [23] Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development
    Wu, Dongmei
    Yang, Qiuju
    Su, Baohua
    Hao, Jia
    Ma, Huirong
    Yuan, Weilan
    Gao, Junhui
    Ding, Feifei
    Xu, Yue
    Wang, Huifeng
    Zhao, Jiangman
    Li, Bingqiang
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [24] Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease
    Karalis, Dean G.
    [J]. MAYO CLINIC PROCEEDINGS, 2009, 84 (04) : 345 - 352
  • [25] Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background
    Bolli, Alessandro
    Di Domenico, Paolo
    Pastorino, Roberta
    Busby, George B.
    Botta, Giordano
    [J]. CIRCULATION, 2021, 143 (14) : 1452 - 1454
  • [26] Autoantibodies to oxidized low-density lipoprotein in coronary artery disease
    Sherer, Y
    Tenenbaum, A
    Blank, M
    Shemesh, J
    Harats, D
    Fisman, EZ
    Praprotnik, S
    Motro, M
    Shoenfeld, Y
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (02) : 149 - 154
  • [27] Changes in sialylation of low-density lipoprotein in coronary artery disease
    Goodarzi, Mohammad Taghi
    Rezaei, Mohsen
    Moadel, Esmaeil
    Homayounfar, Shahram
    Safari, Mohammad Reza
    [J]. EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, 2008, 110 (04) : 302 - 306
  • [28] Management of persons with high risk of coronary heart disease but low serum low-density lipoprotein cholesterol
    Case, CC
    Jacobson, TA
    Roberts, S
    Buckley, A
    Murtaugh, KM
    Sung, JCY
    Gause, D
    Varas, C
    Ballantyne, CM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (09): : 1134 - 1136
  • [29] Optimal Low-Density Lipoprotein Cholesterol for Cardiovascular Prevention: How Low Should We Go?
    Anderson, Todd J.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2017, 33 (03) : 405 - 408
  • [30] Low-density lipoprotein cholesterol lowering in the prevention of CHD: How low should we go?
    Isley W.L.
    [J]. Current Treatment Options in Cardiovascular Medicine, 2006, 8 (4) : 289 - 297
12345